Tabula Rasa HealthCare, Inc.

Informe acción NasdaqGM:TRHC

Capitalización de mercado: US$284.0m

Tabula Rasa HealthCare Dirección

Dirección controles de criterios 3/4

El CEO de Tabula Rasa HealthCare's es Brian Adams , nombrado en Sep 2022, tiene una permanencia de 1.17 años. compensación anual total es $2.30M, compuesta por 19.6% salario y 80.4% primas, incluidas acciones y opciones de la empresa. posee directamente un 1.55% de las acciones de la empresa, por valor de $4.40M. La antigüedad media del equipo directivo y de la junta directiva es de 2.5 años y 5 años, respectivamente.

Información clave

Brian Adams

Chief Executive Officer (CEO)

US$2.3m

Compensación total

Porcentaje del salario del CEO19.6%
Permanencia del CEO1.2yrs
Participación del CEO1.5%
Permanencia media de la dirección2.5yrs
Promedio de permanencia en la Junta Directiva5yrs

Actualizaciones recientes de la dirección

Recent updates

Continuing To Avoid Tabula Rasa HealthCare Inc.

May 19

Does Tabula Rasa HealthCare (NASDAQ:TRHC) Have A Healthy Balance Sheet?

May 11
Does Tabula Rasa HealthCare (NASDAQ:TRHC) Have A Healthy Balance Sheet?

Is Tabula Rasa HealthCare (NASDAQ:TRHC) Using Too Much Debt?

Feb 09
Is Tabula Rasa HealthCare (NASDAQ:TRHC) Using Too Much Debt?

Calculating The Fair Value Of Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC)

Jan 19
Calculating The Fair Value Of Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC)

Why Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) Could Be Worth Watching

Dec 06
Why Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) Could Be Worth Watching

Is Tabula Rasa HealthCare (NASDAQ:TRHC) A Risky Investment?

Nov 05
Is Tabula Rasa HealthCare (NASDAQ:TRHC) A Risky Investment?

Tabula Rasa HealthCare, Inc.'s (NASDAQ:TRHC) Intrinsic Value Is Potentially 84% Above Its Share Price

Jul 26
Tabula Rasa HealthCare, Inc.'s (NASDAQ:TRHC) Intrinsic Value Is Potentially 84% Above Its Share Price

Is Tabula Rasa HealthCare (NASDAQ:TRHC) Using Too Much Debt?

Jun 28
Is Tabula Rasa HealthCare (NASDAQ:TRHC) Using Too Much Debt?

We Discuss Why Tabula Rasa HealthCare, Inc.'s (NASDAQ:TRHC) CEO Compensation May Be Closely Reviewed

Jun 05
We Discuss Why Tabula Rasa HealthCare, Inc.'s (NASDAQ:TRHC) CEO Compensation May Be Closely Reviewed

Tabula Rasa HealthCare, Inc. 2021 Q1 - Results - Earnings Call Presentation

May 07

Tabula Rasa HealthCare, Inc.'s (NASDAQ:TRHC) Intrinsic Value Is Potentially 60% Above Its Share Price

Apr 02
Tabula Rasa HealthCare, Inc.'s (NASDAQ:TRHC) Intrinsic Value Is Potentially 60% Above Its Share Price

Tabula Rasa HealthCare (NASDAQ:TRHC) Is Carrying A Fair Bit Of Debt

Mar 12
Tabula Rasa HealthCare (NASDAQ:TRHC) Is Carrying A Fair Bit Of Debt

Update: Tabula Rasa HealthCare (NASDAQ:TRHC) Stock Gained 51% In The Last Three Years

Feb 19
Update: Tabula Rasa HealthCare (NASDAQ:TRHC) Stock Gained 51% In The Last Three Years

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Brian Adams en comparación con los beneficios de Tabula Rasa HealthCare?
FechaCompensación totalSalarioIngresos de la empresa
Jun 30 2023n/an/a

-US$61m

Mar 31 2023n/an/a

-US$64m

Dec 31 2022US$2mUS$450k

-US$77m

Sep 30 2022n/an/a

-US$72m

Jun 30 2022n/an/a

-US$58m

Mar 31 2022n/an/a

-US$59m

Dec 31 2021US$2mUS$403k

-US$52m

Sep 30 2021n/an/a

-US$70m

Jun 30 2021n/an/a

-US$80m

Mar 31 2021n/an/a

-US$80m

Dec 31 2020US$2mUS$385k

-US$57m

Sep 30 2020n/an/a

-US$57m

Jun 30 2020n/an/a

-US$44m

Mar 31 2020n/an/a

-US$36m

Dec 31 2019US$3mUS$408k

-US$32m

Sep 30 2019n/an/a

-US$36m

Jun 30 2019n/an/a

-US$18m

Mar 31 2019n/an/a

-US$40m

Dec 31 2018US$2mUS$408k

-US$47m

Sep 30 2018n/an/a

-US$26m

Jun 30 2018n/an/a

-US$30m

Mar 31 2018n/an/a

-US$3m

Dec 31 2017US$882kUS$328k

US$13m

Sep 30 2017n/an/a

-US$3m

Jun 30 2017n/an/a

-US$8m

Mar 31 2017n/an/a

-US$7m

Dec 31 2016US$2mUS$278k

-US$3m

Compensación vs. Mercado: La compensación total de Brian($USD2.30M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD1.60M).

Compensación vs. Ingresos: La compensación de Brian ha sido consistente con los resultados de la empresa en el último año.


CEO

Brian Adams (41 yo)

1.2yrs

Permanencia

US$2,301,712

Compensación

Mr. Brian W. Adams serves as President at Tabula Rasa HealthCare, Inc since September 14, 2022. He served as Vice President of Finance at CareKinesis, Inc. since October 2011 until 2014. He had been Co-Pre...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Brian Adams
CEO, President & Director1.2yrsUS$2.30m1.55%
$ 4.4m
Thomas Cancro
Chief Financial Officer1.8yrsUS$1.46m0.41%
$ 1.2m
Michael Greenhalgh
COO & President of Pharmacy Services9.4yrsUS$1.86m1.2%
$ 3.4m
Michael Bruno
VP, Corporate Controller & Chief Accounting Officerless than a yearsin datos0.037%
$ 105.0k
Bob Sullivan
Chief Technology Officer3.3yrssin datossin datos
Phillip Heath
Chief Administrative Officer8.8yrssin datossin datos
Frank Sparacino
Senior Vice President of Investor Relations & Corporate Development3.7yrssin datossin datos
Richard Rew
Chief Legal Officer & Corporate Secretaryless than a yearsin datossin datos
Kathleen Larkin
Chief People Officer1.8yrssin datossin datos
Andrea Speers
Chief of Staffless than a yearsin datossin datos
Kim Browning
Chief of Staff5.5yrssin datossin datos
Alan Stein
Senior Vice President of Healthcare Analytics5.5yrssin datossin datos

2.5yrs

Permanencia media

55yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de TRHC se considera experimentado (2.5 años antigüedad media).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Brian Adams
CEO, President & Directorless than a yearUS$2.30m1.55%
$ 4.4m
Jonathan Schwartz
Independent Director1.2yrsUS$257.50k0.29%
$ 823.1k
Dennis Helling
Independent Director6.7yrsUS$235.53k0.41%
$ 1.2m
Alan Sadowsky
Member of Strategic Advisory Boardno datasin datossin datos
Lawrence Lesko
Member of Strategic Advisory Boardno datasin datossin datos
Jocelyn Konrad
Member of Strategic Advisory Boardno datasin datossin datos
Michael Purcell
Independent Board Chairman5.3yrsUS$257.78k0.52%
$ 1.5m
Samira Beckwith
Independent Director6.3yrsUS$239.47k0.33%
$ 927.1k
Pamela Schweitzer
Independent Director4.7yrsUS$229.67k0.33%
$ 934.6k
Kathrine O'Brien
Independent Director5yrsUS$231.33k0.17%
$ 488.5k
Brian Isetts
Member of Strategic Advisory Boardno datasin datossin datos
Margaret Johnson
Member of Strategic Advisory Boardno datasin datossin datos

5.0yrs

Permanencia media

62.5yo

Promedio de edad

Junta con experiencia: La junta directiva de TRHC se considera experimentada (5 años de antigüedad promedio).